Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—a national population-based study

Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—a national population-based study

Abstract Background Comprehensive readmission morbidity studies after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are scarce. This study aimed to investigate readmissions and in-hospital morbidity after CRS and HIPEC. Methods The national in-hospital patient reg...

Full description

Bibliographic Details
Main Authors: Paul Dranichnikov, Wilhelm Graf, Peter H. Cashin
Format: Article
Language:English
Published: BMC 2020-04-01
Series:World Journal of Surgical Oncology
Subjects:
Readmission
Peritoneal metastases
HIPEC
Morbidity
Gastric resection
Online Access:http://link.springer.com/article/10.1186/s12957-020-01837-4

Internet

http://link.springer.com/article/10.1186/s12957-020-01837-4

Similar Items